• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Ingevity Corporation

    3/10/25 4:30:46 PM ET
    $NGVT
    Major Chemicals
    Industrials
    Get the next $NGVT alert in real time by email
    DEFA14A 1 ef20045157_defa14a.htm DEFA14A

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 14A

    Proxy Statement Pursuant to Section 14(a)
    of the Securities Exchange Act of 1934
    (Amendment No.      )



    Filed by the Registrant   ☒
    Filed by a party other than the Registrant   ☐
     
    Check the appropriate box:
     
    ☐
    Preliminary Proxy Statement
    ☐
    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
    ☐
    Definitive Proxy Statement
    ☐
    Definitive Additional Materials
    ☒
    Soliciting Material Pursuant to §240.14a-12

    INGEVITY CORPORATION

    (Name of Registrant as Specified In Its Charter)


    (Name of Person(s) Filing Proxy Statement, if Other Than The Registrant)

    Payment of Filing Fee (Check the appropriate box):

    ☒
    No fee required.
    ☐
    Fee paid previously with preliminary materials.
    ☐
    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
     

    On March 10, 2025, Ingevity Corporation issued the following press release.
    Ingevity announces appointment of David H. Li as president and CEO

    Li brings 25-year+ record of driving successful corporate transformation, long-term growth and stockholder value creation at premier global specialty materials supplier

    NORTH CHARLESTON, S.C., Mar 10, 2025 – Ingevity Corporation (NYSE:NGVT) today announced that its board of directors has appointed David H. Li as the company’s president and CEO, effective as of April 7, 2025, and that he is expected to join the board of directors following the 2025 Annual Meeting. Li succeeds Ingevity board member, Luis Fernandez-Moreno, who has been serving as interim president and CEO since October 2024. Fernandez-Moreno will remain on Ingevity’s board.

    Li has more than 25 years of experience in the specialty materials industry. He most recently served as CEO, president and a member of the board of CMC Materials, Inc., a global supplier of advanced materials focused on the semiconductor and energy industries, prior to its sale to Entegris, Inc. in 2022.

    “David (Dave) has a broad and proven track record of repositioning businesses across product lines and geographies to achieve substantial growth, strong financial performance and outstanding stockholder returns,” said Ingevity’s board chair, Jean Blackwell. “These accomplishments and his ability to drive strategic execution and organizational excellence across global organizations make Dave the ideal CEO to lead Ingevity and enable the company to realize its full potential as a world class specialty chemicals and materials manufacturer.”

    “It is an honor to step into the president and CEO role at this pivotal time and have the opportunity to build on the strong momentum the Ingevity board and management team have created,” said Li. “Over the course of my career, success has been fueled by building high-performing teams and reshaping portfolios to solve customers’ greatest challenges. I look forward to leveraging my experience to unlock the value within Ingevity and position the company for long-term profitable growth and superior value creation.”

    “On behalf of the board, I would like to thank Luis for his service to Ingevity as interim president and CEO,” said Blackwell. “Under his leadership, Ingevity has undertaken a number of strategic initiatives, including a proactive approach to portfolio management, that have resulted in improved operational performance and free cash flow generation. His work as interim CEO made his input on this hiring decision even more valuable, and we look forward to continuing to benefit from Luis’s experience and leadership as a member of the Ingevity board.”

    About David H. Li

    Li served as chief executive officer, president and a member of the board of CMC Materials from January 2015 to July 2022. Over his tenure and at the time of CMC’s sale to Entegris, the company had delivered a four-fold return to stockholders and reported record revenue of $1.2 billion and adjusted EBITDA margin of 30 percent, in the top-tier of industry peers.

    Before being named chief executive officer and president, Li served as CMC’s vice president of the Asia Pacific region for seven years. Prior to that, he held various senior leadership and management positions at CMC, including in the areas of product line management, operations, supply chain and investor relations.

    Ingevity: Purify, Protect and Enhance

    Ingevity provides products and technologies that purify, protect and enhance the world around us. Through a team of talented and experienced people, we develop, manufacture and bring to market solutions that help customers solve complex problems and make the world more sustainable. We operate in three reporting segments: Performance Materials, which includes activated carbon; Advanced Polymer Technologies, which includes caprolactone polymers; and Performance Chemicals, which includes specialty chemicals and road technologies. Our products are used in a variety of demanding applications, including adhesives, agrochemicals, asphalt paving, certified biodegradable bioplastics, coatings, elastomers, pavement markings and automotive components. Headquartered in North Charleston, South Carolina, Ingevity operates from 31 countries around the world and employs approximately 1,600 people. The company’s common stock is traded on the New York Stock Exchange (NYSE:NGVT). For more information, visit ingevity.com.
     

    About Forward-Looking Statements
    This press release contains “forward-looking statements” within the meaning of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. Such statements generally include the words “will,” “plans,” “intends,” “targets,” “expects,” “outlook,” “believes,” “anticipates” or similar expressions. Forward-looking statements may include, without limitation, the potential benefits of any leadership transition; expected financial positions, guidance, results of operations and cash flows; financing plans; business strategies and expectations. Actual results could differ materially from the views expressed. Factors that could cause actual results to materially differ from those contained in the forward-looking statements, or that could cause other forward-looking statements to prove incorrect, include, without limitation, such factors detailed from time to time in Part I, Item 1A. Risk Factors in our Annual Report on Form 10-K as well as in our other filings with the SEC. These forward-looking statements speak only to management’s beliefs as of the date of this press release. Ingevity assumes no obligation to provide any revisions to, or update, any projections and forward-looking statements contained in this press release.

    Additional Information and Where to Find It
    In connection with Ingevity’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”), Ingevity filed on March 10, 2025 with the Securities and Exchange Commission (“SEC”) a preliminary proxy statement on Schedule 14A (the “Proxy Statement”), containing a form of WHITE proxy card. The Proxy Statement is in preliminary form and Ingevity intends to file and mail to stockholders of record entitled to vote at the 2025 Annual Meeting a definitive proxy statement and other documents, including a WHITE proxy card. This communication is not a substitute for any proxy statement or other document that Ingevity has filed or may file with the SEC in connection with any solicitation by Ingevity. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) FILED BY INGEVITY AND ALL OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION. These documents, including the Proxy Statement (and any amendments or supplements thereto) and other documents filed by Ingevity with the SEC, are available free of charge at the SEC’s website at http://www.sec.gov and at Ingevity’s investor relations website at http://ir.ingevity.com.

    Participants in the Solicitation
    Ingevity, its directors and certain of its executive officers and other employees may be deemed to be participants in the solicitation of proxies from Ingevity stockholders in connection with the matters to be considered at the 2025 Annual Meeting. Information regarding such participants and their respective interests in Ingevity by security holdings or otherwise is set forth in the section entitled “Appendix C: Supplemental Information Regarding Participants in the Solicitation” in the Proxy Statement, which was filed with the SEC on March 10, 2025, and will be included in Ingevity’s definitive proxy statement, once available. Additional information regarding the interests of these participants in the solicitation of proxies in respect of the 2025 Annual Meeting and other relevant materials will be filed with the SEC when they become available. These documents are or will be available free of charge at the SEC’s website at www.sec.gov.

    Contacts

    Media:
    Caroline Monahan
    843-740-2068
    [email protected]

    Kara Brickman / Greg Klassen
    Joele Frank, Wilkinson Brimmer Katcher
    212-355-4449

    Investors:
    John E. Nypaver, Jr.
    843-740-2002
    [email protected]


    On March 10, 2025, Ingevity Corporation issued the following infographic about the appointment of David H. Li as its next president and CEO, which was shared with certain announcement materials.


    David H. Li PRESIDENT & CEO | EFFECTIVE APRIL 7, 2025 Accomplished Leader with +25-Year Track Record of Driving Value-Maximizing Transformation in  Specialty Materials Industry Delivered Strong Results, Execution  and Innovation as President & CE  of CMC Materials Over the course of my  career, success has been  fueled by building highperforming  teams and  reshaping portfolios to  solve customers’ greatest  challenges. I look forward to  leveraging my experience  to unlock the value within  Ingevity and position the  company for long-term  profitable growth and  superior value creation.”  – DAVID LI ~16%  cumulative annual  revenue growth1 RECORD  $1.2B  of revenues2 +1,750  issued and  pending patents2 30%  adjusted EBITDA margin2 ~14%  cumulative annual  operating profit growth1 $6.5B  sale to Entegris  — 35% premium3 ~$2B  of acquisitions, expanding  into electronic materials  and performance solutions ~300% total shareholder returns  compared to ~78% for S&P 4004 Career Highlights President & CEO2015 – 2022 Vice President, Asia  Pacific Region  2008 – 2014 Various senior leadership roles  in product line management,  operations, supply chain, IR  1998 – 2008 Education BS MBA 1. From Fiscal Year 2014 to Q2 Fiscal Year 2022 LTM  2. Fiscal Year 2021 (LTM at the time of the announced sale to Entegris on Dec 15, 2021) 3. Premium at announcement over CMC Materials closing stock price as of Dec 14, 2021, day before announcement of Entegris acquisition 4. From appointment on Jan 1, 2015 to Jul 5, 2022, the last trading day prior to the close of sale to Entegri

    Additional Information and Where to Find It: In connection with Ingevity’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”), Ingevity filed on March 10, 2025 with the Securities and Exchange Commission (“SEC”) a preliminary proxy statement on Schedule 14A (the “Proxy Statement”), containing a form of WHITE proxy card. The Proxy Statement is in preliminary form and Ingevity intends to file and mail to stockholders of record entitled to vote at the 2025 Annual Meeting a definitive proxy statement and other documents, including a WHITE proxy card. This communication is not a substitute for any proxy statement or other document that Ingevity has filed or may file with the SEC in connection with any solicitation by Ingevity. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) FILED BY INGEVITY AND ALL OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION. These documents, including the Proxy Statement (and any amendments or supplements thereto) and other documents filed by Ingevity with the SEC, are available free of charge at the SEC’s website at http://www.sec.gov and at Ingevity’s investor relations website at http://ir.ingevity.com.
     
    Participants in the Solicitation: Ingevity, its directors and certain of its executive officers and other employees may be deemed to be participants in the solicitation of proxies from Ingevity stockholders in connection with the matters to be considered at the Annual Meeting. Information regarding such participants and their respective interests in Ingevity by security holdings or otherwise is set forth in the section entitled “Appendix C: Supplemental Information Regarding Participants in the Solicitation” in the Proxy Statement, which was filed with the SEC on March 10, 2025 and will be included in Ingevity’s definitive proxy statement, once available. Additional information regarding the interests of these participants in the solicitation of proxies in respect of the 2025 Annual Meeting and other relevant materials will be filed with the SEC when they become available. These documents are or will be available free of charge at the SEC’s website at www.sec.gov.


    On March 10, 2025, Ingevity Corporation also shared the following letter with its employees.

    Dear Colleagues,

    I am pleased to announce Ingevity’s board of directors has appointed David H. Li as the company’s president and CEO, effective as of April 7, 2025, and that he is expected to join the board of directors following the 2025 Annual Meeting. You can read today’s press release here
    https://www.ingevity.com/news/press-releases/ingevity-announces-appointment-of-david-h-li-as-president-and-ceo/.
     
    David (Dave) is highly qualified to lead the continued execution of our strategy. He brings more than 25 years of experience in the specialty materials industry, most recently serving as CEO, president and a member of the board of CMC Materials, Inc., a global supplier of advanced materials focused on the semiconductor and energy industries, from January 2015 to July 2022. Before being named chief executive officer and president, Dave served as vice president of the Asia Pacific region for seven years. Prior to that, he held various senior leadership and management positions at CMC Materials, including in the areas of product line management, operations, supply chain and investor relations.
     
    Over his career, Dave has demonstrated a record of delivering growth across innovation-led product lines and geographic regions, while building close relationships with customers and developing leaders throughout his company. He is committed to shaping corporate culture to achieve greater employee and customer satisfaction, propel growth and enhance shareholder value.
     
    On behalf of the board, I would like to thank Luis Fernandez-Moreno for his service to Ingevity as interim president and CEO. Under his leadership, Ingevity has undertaken a number of strategic initiatives, that have resulted in improved operational performance and free cash flow generation, and we look forward to continuing to benefit from Luis’ experience and leadership as a member of the Ingevity board.
     
    Luis’ work as interim CEO made his input on this hiring decision even more valuable, and he had this to share. “I am honored that I had the opportunity to serve as CEO, and excited to welcome a strong leader to build on the work we have done. Dave is an excellent choice to lead our talented team, and I look forward to working through a smooth leadership transition together.”
     
    Thank you all for your continued commitment to Ingevity. As a company, we worked hard in 2024 to gain momentum for future growth, and our results show the success of those efforts. We are confident Dave will build on that foundation and provide leadership that will enable Ingevity to realize its full potential as a world class specialty chemicals and materials company.
     
    Please join me in extending a warm welcome to David H. Li as the new President and CEO of Ingevity!
     
    Best regards,
     
    Jean Blackwell
    Chair, Board of Directors

    Additional Information and Where to Find It

    In connection with Ingevity’s 2025 annual meeting of stockholders (the “2025 Annual Meeting”), Ingevity filed on March 10, 2025 with the Securities and Exchange Commission (“SEC”) a preliminary proxy statement on Schedule 14A (the “Proxy Statement”), containing a form of WHITE proxy card. The Proxy Statement is in preliminary form and Ingevity intends to file and mail to stockholders of record entitled to vote at the 2025 Annual Meeting a definitive proxy statement and other documents, including a WHITE proxy card. This communication is not a substitute for any proxy statement or other document that Ingevity has filed or may file with the SEC in connection with any solicitation by Ingevity. BEFORE MAKING ANY VOTING DECISION, INVESTORS AND STOCKHOLDERS ARE URGED TO READ THE PROXY STATEMENT (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) FILED BY INGEVITY AND ALL OTHER RELEVANT DOCUMENTS FILED WITH THE SEC CAREFULLY AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN IMPORTANT INFORMATION. These documents, including the Proxy Statement (and any amendments or supplements thereto) and other documents filed by Ingevity with the SEC, are available free of charge at the SEC’s website at http://www.sec.gov and at Ingevity’s investor relations website at http://ir.ingevity.com.


    Participants in the Solicitation

    Ingevity, its directors and certain of its executive officers and other employees may be deemed to be participants in the solicitation of proxies from Ingevity stockholders in connection with the matters to be considered at the 2025 Annual Meeting. Information regarding such participants and their respective interests in Ingevity by security holdings or otherwise is set forth in the section entitled “Appendix C: Supplemental Information Regarding Participants in the Solicitation” in the Proxy Statement, which was filed with the SEC on March 10, 2025, and will be included in Ingevity’s definitive proxy statement, once available. Additional information regarding the interests of these participants in the solicitation of proxies in respect of the 2025 Annual Meeting and other relevant materials will be filed with the SEC when they become available. These documents are or will be available free of charge at the SEC’s website at www.sec.gov.


    On March 10, 2025, Ingevity Corporation also announced the appointment of David H. Li as its next president and CEO on its social media channels by posting the below image and linking to the press release described above.
     
     


    Get the next $NGVT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $NGVT

    DatePrice TargetRatingAnalyst
    2/26/2025$62.00 → $65.00Market Perform → Outperform
    BMO Capital Markets
    8/7/2024$58.00Market Perform → Market Outperform
    CJS Securities
    4/22/2024$52.00 → $62.00Hold → Buy
    Jefferies
    11/6/2023$49.00Market Outperform → Market Perform
    CJS Securities
    10/3/2023$62.00 → $53.00Buy → Hold
    Loop Capital
    8/7/2023$71.00 → $60.00Outperform → Market Perform
    BMO Capital Markets
    7/27/2023$64.00 → $75.00Hold → Buy
    Loop Capital
    5/5/2023$92.00 → $64.00Buy → Hold
    Loop Capital
    More analyst ratings

    $NGVT
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Segal Francis David was granted 396 shares, increasing direct ownership by 7% to 6,051 units (SEC Form 4)

    4 - Ingevity Corp (0001653477) (Issuer)

    1/6/26 1:39:45 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Director Willis J Kevin was granted 479 shares, increasing direct ownership by 6% to 8,779 units (SEC Form 4)

    4 - Ingevity Corp (0001653477) (Issuer)

    1/6/26 1:38:10 PM ET
    $NGVT
    Major Chemicals
    Industrials

    New insider Clontz Clarence Reid Jr. claimed ownership of 7,029 shares (SEC Form 3)

    3 - Ingevity Corp (0001653477) (Issuer)

    12/18/25 6:13:09 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    SEC Filings

    View All

    Ingevity Corporation filed SEC Form 8-K: Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Regulation FD Disclosure

    8-K - Ingevity Corp (0001653477) (Filer)

    1/5/26 6:39:42 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity Corporation filed SEC Form 8-K: Leadership Update, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Ingevity Corp (0001653477) (Filer)

    12/8/25 6:56:30 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity Corporation filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Ingevity Corp (0001653477) (Filer)

    12/8/25 6:54:59 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ingevity named to 2026 America's Most Responsible Companies list by Newsweek

    Ingevity Corporation (NYSE:NGVT) today announced it has been named to Newsweek's America's Most Responsible Companies list for the fourth consecutive year. The 2026 award recognizes the 600 top publicly traded companies in the United States for strong performance across corporate responsibility standards. "Being recognized on Newsweek's 2026 list of America's Most Responsible Companies is a proud moment for Ingevity," said Dave Li, President and CEO, Ingevity. "This honor reflects the integrity and care our teams bring to everything we do. By staying true to responsible growth and strengthening the communities we serve, we're building a resilient foundation for long-term success." The 2

    1/20/26 9:00:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity announces successful completion of sale of North Charleston crude tall oil refinery and majority of Industrial Specialties product line

    Transaction reduces portfolio volatility, strengthens Ingevity's margin and cash flow profile and enhances strategic flexibility Ingevity Corporation (NYSE:NGVT) today announced the completion of the previously disclosed sale of its North Charleston Crude Tall Oil (CTO) refinery assets and the majority of its Performance Chemicals Industrial Specialties product line to Mainstream Pine Products, LLC (Mainstream). Per the terms of the agreement, the all-cash transaction includes $110 million at closing plus potential contingent consideration ranging from $0 to $19 million, subject to the achievement of future business performance milestones. The transaction is subject to customary adjustmen

    1/5/26 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity announces results of portfolio review, including plans to explore strategic alternatives for Advanced Polymer Technologies segment and Road Markings business

    Potential divestitures would further enhance portfolio to focus on core businesses which carry best-in-class margins and cash flow generation Ingevity Corporation (NYSE:NGVT) today announced it has completed the company's previously disclosed portfolio review process and is in the early stages of exploring strategic alternatives for its Advanced Polymer Technologies (APT) segment and Performance Chemicals Road Markings business, including a potential sale of one or both. "Ingevity's leadership team and Board remain focused on unlocking long-term value for shareholders," said Dave Li, president and CEO of Ingevity. "Having conducted a thorough review of the Ingevity portfolio, we have dete

    12/8/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Ingevity upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded Ingevity from Market Perform to Outperform and set a new price target of $65.00 from $62.00 previously

    2/26/25 7:15:06 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity upgraded by CJS Securities with a new price target

    CJS Securities upgraded Ingevity from Market Perform to Market Outperform and set a new price target of $58.00

    8/7/24 9:18:13 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity upgraded by Jefferies with a new price target

    Jefferies upgraded Ingevity from Hold to Buy and set a new price target of $62.00 from $52.00 previously

    4/22/24 7:39:26 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Leadership Updates

    Live Leadership Updates

    View All

    Ingevity announces key leadership transitions

    Ingevity Corporation (NYSE:NGVT) today announced pivotal executive leadership changes as it completes its strategic portfolio review and positions the company for the future. Chief financial officer transition Mary Dean Hall, executive vice president and chief financial officer (CFO), will transition from her current role effective May 1, 2026, and continue to support the company in an advisory capacity for a period of one year. Hall has served as CFO since 2021, playing a critical role in strengthening Ingevity's financial foundation, enhancing operational discipline and supporting strategic growth initiatives. Under her financial leadership, the company achieved significant margin expan

    12/8/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity names Ruth Castillo as senior vice president and president of Performance Materials

    Veteran industry leader joins Ingevity to accelerate innovation and strategic growth across company's high performance activated carbon portfolio Ingevity Corporation (NYSE:NGVT) today announced that, effective November 10, 2025, Ruth Castillo has been appointed as president of Performance Materials, the company's unique activated carbon segment which has a long track record of consistent strong financial performance. She will also join Ingevity's executive leadership team as senior vice president. Castillo most recently served as vice president of global chemicals at Avantor. She brings more than 25 years of global experience in the chemicals and materials industries, with proven abili

    10/23/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity announces departure of Performance Materials segment president, Ed Woodcock

    Ingevity Corporation (NYSE:NGVT) today announced Ed Woodcock, executive vice president and president, Performance Materials, departed the company effective July 1, 2025. Woodcock's departure follows a 37-year career with the company. "Ed Woodcock's leadership has been foundational to the successful growth of Ingevity's Performance Materials activated carbon business as the industry leader in automotive emissions capture," said Ingevity president and CEO, Dave Li. "During his extensive career with the company, Ed drove global expansion of the business, delivered consistently strong profitability and positioned the Performance Materials segment for growth in the hybrid and electric vehicle

    7/1/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Financials

    Live finance-specific insights

    View All

    Ingevity announces results of portfolio review, including plans to explore strategic alternatives for Advanced Polymer Technologies segment and Road Markings business

    Potential divestitures would further enhance portfolio to focus on core businesses which carry best-in-class margins and cash flow generation Ingevity Corporation (NYSE:NGVT) today announced it has completed the company's previously disclosed portfolio review process and is in the early stages of exploring strategic alternatives for its Advanced Polymer Technologies (APT) segment and Performance Chemicals Road Markings business, including a potential sale of one or both. "Ingevity's leadership team and Board remain focused on unlocking long-term value for shareholders," said Dave Li, president and CEO of Ingevity. "Having conducted a thorough review of the Ingevity portfolio, we have dete

    12/8/25 6:30:00 AM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity announces dates for third quarter 2025 earnings release and webcast

    Ingevity Corporation (NYSE:NGVT) announced today that it will release its third quarter 2025 earnings after the stock market close on Wednesday, November 5, 2025. The company will host a live webcast on Thursday, November 6, at 10:00 a.m. (Eastern) to discuss third quarter 2025 fiscal results. The webcast can be accessed here or on the investors section of Ingevity's website. Participants may also listen to the conference call by dialing 833 470 1428 (inside the U.S.) and entering access code 871022. Callers outside the U.S. can find global dial-in numbers here. For those unable to join the live event, a recording will be available beginning at approximately 2:00 p.m. (Eastern) on Novem

    10/23/25 4:15:00 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Ingevity reports second quarter 2025 financial results

    HIGHLIGHTS: Net sales of $365.1 million, down 7% compared to prior year, primarily due to lower sales in Performance Chemicals Net loss of $146.5 million and diluted loss per share of $4.02 included an Advanced Polymer Technologies pre-tax non-cash goodwill impairment charge of $183.8 million Adjusted earnings of $51.1 million were up 39% and diluted adjusted earnings per share of $1.39 was up 38% Adjusted EBITDA of $110.0 million increased 9% and adjusted EBITDA margin improved to 30.1% primarily due to the successful execution of repositioning actions in Performance Chemicals Operating cash flow of $79.0 million with free cash flow of $66.8 million Ingevity raises the lo

    8/4/25 4:15:00 PM ET
    $NGVT
    Major Chemicals
    Industrials

    $NGVT
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Ingevity Corporation

    SC 13G/A - Ingevity Corp (0001653477) (Subject)

    11/12/24 3:54:24 PM ET
    $NGVT
    Major Chemicals
    Industrials

    Amendment: SEC Form SC 13G/A filed by Ingevity Corporation

    SC 13G/A - Ingevity Corp (0001653477) (Subject)

    11/4/24 11:52:25 AM ET
    $NGVT
    Major Chemicals
    Industrials

    SEC Form SC 13D/A filed by Ingevity Corporation (Amendment)

    SC 13D/A - Ingevity Corp (0001653477) (Subject)

    2/28/24 5:30:32 PM ET
    $NGVT
    Major Chemicals
    Industrials